This brand name is authorized in Nigeria.
The drug SOGALIS contains one active pharmaceutical ingredient (API):
1
|
UNII
742SXX0ICT - TADALAFIL
|
|
Tadalafil is a selective, reversible inhibitor of cyclic guanosine monophosphate (cGMP)-specific phosphodiesterase type 5 (PDE5). When sexual stimulation causes the local release of nitric oxide, inhibition of PDE5 by tadalafil produces increased levels of cGMP in the corpus cavernosum. This results in smooth muscle relaxation and inflow of blood into the penile tissues, thereby producing an erection. The effect of PDE5 inhibition on cGMP concentration in the corpus cavernosum is also observed in the smooth muscle of the prostate, the bladder and their vascular supply. The resulting vascular relaxation increases blood perfusion which may be the mechanism by which symptoms of benign prostatic hyperplasia are reduced. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| B4-5796 | Tablet | SOGALIS TABLET TAB 20 mg 1 X 4 | 136 CMS-PP-384675 SOGALIS TABLET TADALAFIL TABLET Tadalafil Active 20 mg Microcrystalline Cellulose Filler 131.00 Starch Binder 209.90 Croscarmellose Sodium Super-Disintegrant 4.00 Povidone Solvent 10.00 Sodium Lauryl Sulphate Surfactant 2.00 Purified Water Solvent 0.15 ml Methyl Paraben (Methyl Hydroxy Benzoate) Preservative 0.50 Propyl Paraben (Propyl Hydroxy Benzoate) Preservative 0.10 Starch Binder 17.50 Purified Talc Glidant 7.00 Croscarmellose Sodium Lubricants 8.00, Hydroxy Propyl Methyl Cellulose (Hypromellose) Polymer 5.00 B4-5796 Drugs Imported Products 1X4 Prescription Only Medicine (POM) 11/14/2023 TEKA PHARMACEUTICALCOMPANY LTD, ,ZUNGERU ROAD, NOMANSLAND KANO KANO 7066430624 tekapharmaceuticalco@outlook.com HAB PHARMACEUTICALS & RESEARCH LTD , 10-PHARMA CITY, SIDCUL, SELAQUI, DEHRADUN 248 011, INDIA. , India | 30/11/2023 |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
| ATC Group | Classification | |
|---|---|---|
| G04BE08 | Tadalafil | G Genito urinary system and sex hormones → G04 Urologicals → G04B Other urologicals, incl. antispasmodics → G04BE Drugs used in erectile dysfunction |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | B4-5796 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.